[72] The pathophysiology of BED is not fully understood, but it is believed to involve dysfunctional dopaminergic reward circuitry along the cortico-striatal-thalamic-cortical loop
Its about providing care that can improve their lives. Moving toward medications In a dramatic shift in pediatric weight-loss options, the Food and Drug Administration approved a GLP-1 medication the daily injectable liraglutide for kids 12 and up in 2020, and a second the weekly injectable semaglutide in 2022
Studies such as the LEADER trial (liraglutide), SUSTAIN-6 (semaglutide), and REWIND (dulaglutide) have shown reductions in major adverse cardiovascular events, including heart attack and stroke, in people with type 2 diabetes and established cardiovascular disease or high cardiovascular risk
Cancer 12 , 252264 (2012)
Ive been able to stick to my healthy choices without feeling like Im starving myself